Regulatory Gaps in Drug Compounding: Implications for Patient Safety, Innovation, and Fraud

SSRN Electronic Journal
doi 10.2139/ssrn.3182087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Gaps in the Continuity of Care and Progress on Patient Safety

BMJ
2000English

Balancing Drug Availability and Patient Safety

Nature Clinical Practice Nephrology
2007English

Innovation or Fraud?

South African Journal of Sports Medicine
2007English

Chronic Pain and Analgesic Use in CKD: Implications for Patient Safety

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2015English

Equipment Failure: Conducts of Nurses and Implications for Patient Safety

Revista brasileira de enfermagem
MedicineNursing
2018English

Confronting the “Fraud Bottleneck”: Private Sanctions for Fraud and Their Implications for Justice

Journal of Criminological Research, Policy and Practice
SociologyPublic AdministrationHealthPolitical ScienceSocial PsychologyLaw
2015English

The Consequences of ‘Brexit’ for Drug Discovery and Development, and the Regulatory Implications

Expert Opinion on Drug Discovery
Drug Discovery
2018English

The Professional Culture Among Physicians in Sweden: Potential Implications for Patient Safety

BMC Health Services Research
Health Policy
2018English

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities

Safety and Risk of Pharmacotherapy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy